TNFSF10 and glioblastoma: In contrast, HRK overexpression cooperated with TRAIL in U87MG and LN18 TRAIL mid-sensitive GBM cell lines, where HRK-overexpressing cells had better response to TRAIL treatment (Fig. 4b).